Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
32
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Pitts Peter Joe | Executive Chairman, Director | 2 | $0 | $0 | 2026-07-24 |
| FRENKEL JACOB A | Director | 7 | $0 | $0 | 2026-07-24 |
| Dagher Ibrahim B. | Director | 3 | $0 | $22.1K | 2026-02-26 |
| Naor Nir | Director | 3 | $0 | $0 | 2026-02-26 |
| Bairu Menghisteab | Director | 2 | $0 | $0 | 2026-02-26 |
| Lindborg Stacy | EVP, Head Global Clin Research | 10 | $2.22M | $0 | 2026-02-26 |
| Polverino Anthony J. | Director | 12 | $0 | $0 | 2026-02-26 |
| Patlis Alla | See Remarks | 3 | $0 | $0 | 2026-02-26 |
| Yablonka Uri | EVP and Chief Business Officer | 16 | $8.0K | $0 | 2026-02-26 |
| Lebovits Chaim | See Remarks | 38 | $284.8K | $0 | 2026-02-26 |
| ARBEL IRIT | Director | 21 | $10.7K | $48.9K | 2026-02-26 |
| HARTOUNIAN HARTOUN | EVP, Chief Operating Officer | 4 | $0 | $0 | 2026-02-26 |
| Taylor Kirk | Chief Medical Officer | 2 | $0 | $0 | 2023-05-01 |
| Kern Ralph Dr. | COO and Chief Medical Officer | 11 | $29.6K | $0 | 2022-03-06 |
| Almenoff June Sherie | Director | 6 | $25.0K | $0 | 2021-12-15 |
| TAUB MALCOLM S | Director | 14 | $0 | $145.6K | 2021-12-15 |
| Abbhi Sankesh | Director | 3 | $607.7K | $0 | 2021-12-10 |
| Shah Preetam | EVP, CFO and Treasurer | 5 | $45.9K | $0 | 2020-12-30 |
| Waclawski Anthony | See Remarks | 2 | $0 | $0 | 2020-09-08 |
| Setboun David | EVP and COO | 2 | $64.8K | $0 | 2020-07-16 |
| ACC International Holdings Ltd. | Other | 40 | $507.3K | $960.6K | 2020-07-16 |
| Araya Arturo | Director | 6 | $11.7K | $0 | 2019-12-24 |
| Schor Chen | Director | 5 | $0 | $0 | 2018-11-30 |
| Rubin Eyal | CFO and Treasurer | 2 | $0 | $0 | 2017-11-20 |
| SHORR ROBERT G L | Director | 9 | $0 | $57.7K | 2017-11-10 |
| Friedman Mordechai | Director | 8 | $0 | $12.8K | 2016-06-22 |
| Pinkas Alon | Director | 5 | $0 | $0 | 2016-06-22 |
| Bibring Yoram | Chief Financial Officer | 4 | $147.0K | $0 | 2015-12-01 |
| Fiorino Anthony S. | Chief Executive Officer | 8 | $10.0K | $0 | 2014-10-15 |
| Israeli Avi | Director | 4 | $0 | $0 | 2014-04-13 |
| Sossover Liat | Chief Financial Officer | 3 | $0 | $0 | 2013-12-31 |
| Harel Adrian | Chief Executive Officer | 2 | $0 | $0 | 2012-08-01 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Pitts Peter Joe | Executive Chairman | A Award deriv | 2026-07-24 | 2026-07-28 | 900,000 | — | $0 | 900,000 | SEC↗ |
| FRENKEL JACOB A | Director | A Award | 2026-07-24 | 2026-07-28 | 100,000 | — | $0 | 343,777 | SEC↗ |
| FRENKEL JACOB A | Director | A Award | 2026-07-24 | 2026-07-28 | 100,000 | — | $0 | 343,777 | SEC↗ |
| Pitts Peter Joe | Executive Chairman, Director | A Award deriv | 2026-07-24 | 2026-07-28 | 900,000 | — | $0 | 900,000 | SEC↗ |
| Dagher Ibrahim B. | Director | A Award deriv | 2026-02-26 | 2026-05-20 | 225,000 | $0.70 | $157.5K | 225,000 | SEC↗ |
| Naor Nir | Director | A Award deriv | 2026-02-26 | 2026-05-20 | 180,000 | $0.70 | $126.0K | 180,000 | SEC↗ |
| Lindborg Stacy | Director | A Award deriv | 2026-02-26 | 2026-05-20 | 150,000 | $0.70 | $105.0K | 150,000 | SEC↗ |
| HARTOUNIAN HARTOUN | Director | A Award deriv | 2026-02-26 | 2026-05-20 | 225,000 | $0.70 | $157.5K | 225,000 | SEC↗ |
| Polverino Anthony J. | Director | A Award deriv | 2026-02-26 | 2026-05-20 | 150,000 | $0.70 | $105.0K | 150,000 | SEC↗ |
| Bairu Menghisteab | Director | A Award deriv | 2026-02-26 | 2026-05-20 | 150,000 | $0.70 | $105.0K | 150,000 | SEC↗ |
| ARBEL IRIT | Director | A Award | 2026-02-26 | 2026-05-29 | 120,000 | — | $0 | 161,054 | SEC↗ |
| FRENKEL JACOB A | Director | A Award | 2026-02-26 | 2026-05-29 | 200,000 | — | $0 | 243,777 | SEC↗ |
| Patlis Alla | See Remarks | A Award | 2026-02-26 | 2026-05-29 | 100,000 | — | $0 | 144,349 | SEC↗ |
| Yablonka Uri | EVP & Chief Business Officer | A Award | 2026-02-26 | 2026-05-29 | 150,000 | — | $0 | 218,464 | SEC↗ |
| Lebovits Chaim | President & CEO | A Award | 2026-02-26 | 2026-05-29 | 1,800,000 | — | $0 | 2,000,960 | SEC↗ |
| ARBEL IRIT | Director | A Award | 2025-01-01 | 2025-01-03 | 30,666 | — | $0 | 41,054 | SEC↗ |
| Bairu Menghisteab | Director | A Award | 2025-01-01 | 2025-01-03 | 24,000 | — | $0 | 24,000 | SEC↗ |
| HARTOUNIAN HARTOUN | EVP, Chief Operating Officer | A Award | 2025-01-01 | 2025-01-03 | 50,000 | — | $0 | 52,000 | SEC↗ |
| Lindborg Stacy | Director | A Award | 2025-01-01 | 2025-01-03 | 20,000 | — | $0 | 48,229 | SEC↗ |
| Naor Nir | Director | A Award | 2025-01-01 | 2025-01-03 | 30,666 | — | $0 | 31,465 | SEC↗ |
| Patlis Alla | See Remarks | A Award | 2025-01-01 | 2025-01-03 | 40,000 | — | $0 | 44,349 | SEC↗ |
| Yablonka Uri | EVP & Chief Business Officer | A Award | 2025-01-01 | 2025-01-03 | 20,000 | — | $0 | 68,464 | SEC↗ |
| Yablonka Uri | EVP & Chief Business Officer | A Award | 2025-01-01 | 2025-01-03 | 40,000 | — | $0 | 48,464 | SEC↗ |
| Polverino Anthony J. | Director | A Award | 2025-01-01 | 2025-01-03 | 24,000 | — | $0 | 25,730 | SEC↗ |
| FRENKEL JACOB A | Director | A Award | 2025-01-01 | 2025-01-03 | 40,000 | — | $0 | 43,777 | SEC↗ |
| Lebovits Chaim | President & CEO | A Award | 2025-01-01 | 2025-01-03 | 120,000 | — | $0 | 200,960 | SEC↗ |
| Dagher Ibrahim B. | Chief Medical Officer | A Award | 2025-01-01 | 2025-01-07 | 50,000 | — | $0 | 66,849 | SEC↗ |
| Lebovits Chaim | President & CEO | P Buy | 2024-10-01 | 2024-10-02 | 1,836 | $3.43 | $6.3K | 80,960 | SEC↗ |
| Lebovits Chaim | President & CEO | P Buy | 2024-09-30 | 2024-10-02 | 22,000 | $0.23 | $5.1K | 1,186,865 | SEC↗ |
| Dagher Ibrahim B. | Chief Medical Officer | S Sale | 2024-07-19 | 2024-07-24 | 63,000 | $0.35 | $22.1K | 0 | SEC↗ |
| HARTOUNIAN HARTOUN | EVP, Chief Operating Officer | A Award deriv | 2024-06-24 | 2024-06-25 | 60,000 | — | $0 | 60,000 | SEC↗ |
| HARTOUNIAN HARTOUN | EVP, Chief Operating Officer | A Award | 2024-06-24 | 2024-06-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Lebovits Chaim | President & CEO | P Buy | 2024-05-28 | 2024-07-31 | 15,000 | $0.52 | $7.8K | 1,164,865 | SEC↗ |
| Lebovits Chaim | President & CEO | A Award | 2024-05-28 | 2024-06-03 | 15,000 | $0.52 | $7.8K | 1,164,865 | SEC↗ |
| Lebovits Chaim | President & CEO | P Buy | 2024-05-22 | 2024-07-31 | 25,000 | $0.64 | $16.0K | 1,149,865 | SEC↗ |
| Lebovits Chaim | President & CEO | A Award | 2024-05-22 | 2024-05-23 | 25,000 | $0.64 | $16.0K | 1,149,865 | SEC↗ |
| Lebovits Chaim | President & CEO | P Buy | 2024-05-21 | 2024-07-31 | 25,000 | $0.58 | $14.5K | 1,124,865 | SEC↗ |
| Lebovits Chaim | President & CEO | A Award | 2024-05-21 | 2024-05-23 | 25,000 | $0.58 | $14.5K | 1,124,865 | SEC↗ |
| Lebovits Chaim | President & CEO | P Buy | 2024-05-13 | 2024-07-31 | 10,000 | $0.49 | $4.9K | 1,099,865 | SEC↗ |
| Lebovits Chaim | President & CEO | A Award | 2024-05-13 | 2024-05-14 | 10,000 | $0.49 | $4.9K | 1,099,865 | SEC↗ |
| Lebovits Chaim | President & CEO | P Buy | 2024-05-11 | 2024-07-31 | 10,000 | $0.47 | $4.7K | 1,089,865 | SEC↗ |
| Lebovits Chaim | President & CEO | A Award | 2024-05-11 | 2024-05-14 | 10,000 | $0.47 | $4.7K | 1,089,865 | SEC↗ |
| Lebovits Chaim | President & CEO | P Buy | 2024-05-10 | 2024-07-31 | 20,000 | $0.47 | $9.4K | 1,079,865 | SEC↗ |
| Lebovits Chaim | President & CEO | A Award | 2024-05-10 | 2024-05-14 | 20,000 | $0.47 | $9.4K | 1,079,865 | SEC↗ |
| Lebovits Chaim | President & CEO | P Buy | 2024-05-07 | 2024-07-31 | 66,300 | $0.37 | $24.5K | 1,059,865 | SEC↗ |
| Lebovits Chaim | President & CEO | A Award | 2024-05-07 | 2024-05-07 | 66,300 | $0.37 | $24.5K | 1,059,865 | SEC↗ |
| Lebovits Chaim | President & CEO | P Buy | 2024-05-06 | 2024-07-31 | 135,000 | $0.38 | $51.3K | 993,565 | SEC↗ |
| Lebovits Chaim | President & CEO | A Award | 2024-05-06 | 2024-05-07 | 135,000 | $0.38 | $51.3K | 993,565 | SEC↗ |
| Lebovits Chaim | President & CEO | P Buy | 2024-04-19 | 2024-07-31 | 15,000 | $0.52 | $7.8K | 858,565 | SEC↗ |
| Lebovits Chaim | President & CEO | A Award | 2024-04-19 | 2024-04-25 | 15,000 | $0.52 | $7.8K | 858,565 | SEC↗ |
| Lebovits Chaim | President & CEO | P Buy | 2024-04-18 | 2024-07-31 | 115,072 | $0.53 | $61.0K | 843,565 | SEC↗ |
| Lebovits Chaim | President & CEO | A Award | 2024-04-18 | 2024-04-19 | 115,072 | $0.53 | $61.0K | 843,565 | SEC↗ |
| Lebovits Chaim | President & CEO | P Buy | 2024-04-17 | 2024-07-31 | 130,000 | $0.55 | $71.5K | 728,493 | SEC↗ |
| Lebovits Chaim | President & CEO | A Award | 2024-04-17 | 2024-04-19 | 130,000 | $0.55 | $71.5K | 728,493 | SEC↗ |
| Lebovits Chaim | President & CEO | A Award | 2024-03-11 | 2024-03-13 | 305,198 | — | $0 | 598,493 | SEC↗ |
| Patlis Alla | See Remarks | A Award | 2024-03-11 | 2024-03-13 | 65,246 | — | $0 | 65,246 | SEC↗ |
| Yablonka Uri | EVP & Chief Business Officer | A Award | 2024-03-11 | 2024-03-13 | 109,426 | — | $0 | 126,969 | SEC↗ |
| Lindborg Stacy | Co-Chief Executive Officer | A Award | 2024-03-11 | 2024-03-13 | 241,935 | — | $0 | 423,435 | SEC↗ |
| Lindborg Stacy | Co-Chief Executive Officer | P Buy | 2023-09-01 | 2023-09-05 | 11,500 | $1.77 | $20.4K | 181,500 | SEC↗ |
| Lebovits Chaim | President & CEO | A Award | 2023-08-02 | 2023-08-04 | 31,185 | — | $0 | 293,295 | SEC↗ |
| Lindborg Stacy | Co-Chief Executive Officer | A Award | 2023-08-02 | 2023-08-07 | 35,000 | — | $0 | 170,000 | SEC↗ |
| Naor Nir | Director | A Award | 2023-06-19 | 2023-06-21 | 11,999 | — | $0 | 11,999 | SEC↗ |
| Taylor Kirk | Chief Medical Officer | A Award deriv | 2023-05-01 | 2023-05-01 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Taylor Kirk | Chief Medical Officer | A Award | 2023-05-01 | 2023-05-01 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Lindborg Stacy | Co-Chief Executive Officer | A Award | 2023-04-20 | 2023-04-24 | 75,000 | — | $0 | 135,000 | SEC↗ |
| Lebovits Chaim | President & Co-CEO | A Award | 2023-04-20 | 2023-04-24 | 75,000 | — | $0 | 262,110 | SEC↗ |
| Lindborg Stacy | Co-Chief Executive Officer | A Award | 2022-12-07 | 2023-01-04 | 35,000 | — | $0 | 60,000 | SEC↗ |
| Lebovits Chaim | Chief Executive Officer | A Award | 2022-09-18 | 2023-01-04 | 31,185 | — | $0 | 187,110 | SEC↗ |
| FRENKEL JACOB A | Director | A Award deriv | 2022-04-06 | 2022-04-08 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Kern Ralph Dr. | COO and Chief Medical Office | A Award | 2022-03-06 | 2022-03-14 | 35,885 | — | $0 | 223,310 | SEC↗ |
| Polverino Anthony J. | Director | A Award | 2022-02-01 | 2022-02-03 | 3,882 | — | $0 | 25,960 | SEC↗ |
| ARBEL IRIT | Director | A Award deriv | 2021-12-15 | 2021-12-17 | 25,333 | — | $0 | 25,333 | SEC↗ |
| Yablonka Uri | Director | A Award deriv | 2021-12-15 | 2021-12-17 | 13,333 | — | $0 | 13,333 | SEC↗ |
| Almenoff June Sherie | Director | A Award | 2021-12-15 | 2021-12-17 | 2,000 | — | $0 | 6,000 | SEC↗ |
| Polverino Anthony J. | Director | A Award | 2021-12-15 | 2021-12-17 | 2,000 | — | $0 | 22,078 | SEC↗ |
| TAUB MALCOLM S | Director | A Award | 2021-12-15 | 2021-12-17 | 12,000 | — | $0 | 77,332 | SEC↗ |
| Yablonka Uri | Director | A Award deriv | 2021-12-10 | 2021-12-10 | 13,333 | — | $0 | 13,333 | SEC↗ |
| FRENKEL JACOB A | Director | A Award deriv | 2021-12-10 | 2021-12-10 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ARBEL IRIT | Director | A Award deriv | 2021-12-10 | 2021-12-10 | 25,333 | — | $0 | 25,333 | SEC↗ |
| Almenoff June Sherie | Director | A Award | 2021-12-10 | 2021-12-10 | 2,000 | — | $0 | 4,000 | SEC↗ |
| Abbhi Sankesh | Director | A Award | 2021-12-10 | 2021-12-10 | 6,666 | — | $0 | 11,323 | SEC↗ |
| Polverino Anthony J. | Director | A Award | 2021-12-10 | 2021-12-10 | 2,216 | — | $0 | 18,078 | SEC↗ |
| Polverino Anthony J. | Director | A Award | 2021-12-10 | 2021-12-10 | 2,000 | — | $0 | 20,078 | SEC↗ |
| TAUB MALCOLM S | Director | A Award | 2021-12-10 | 2021-12-10 | 12,000 | — | $0 | 65,332 | SEC↗ |
| Lebovits Chaim | Chief Executive Officer | A Award | 2021-12-10 | 2021-12-10 | 31,185 | — | $0 | 155,925 | SEC↗ |
| Kern Ralph Dr. | COO and Chief Medical Office | A Award | 2021-12-10 | 2021-12-10 | 35,885 | — | $0 | 187,425 | SEC↗ |
| Shah Preetam | EVP, CFO and Treasurer | F Tax w/h | 2020-12-30 | 2020-12-31 | 25,000 | $4.64 | $116.0K | 11,600 | SEC↗ |
| Lindborg Stacy | EVP, Head Global Clin Resear | P Buy deriv | 2020-11-17 | 2020-11-19 | 200 | $11000.00 | $2.20M | 200 | SEC↗ |
| Waclawski Anthony | See Remarks | A Award deriv | 2020-09-08 | 2020-09-10 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Waclawski Anthony | See Remarks | A Award | 2020-09-08 | 2020-09-10 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Lebovits Chaim | Chief Executive Officer | A Award | 2020-07-26 | 2020-07-31 | 31,185 | — | $0 | 124,740 | SEC↗ |
| ACC International Holdings Ltd | Other | S Sale | 2020-07-16 | 2020-07-16 | 7,823 | $13.47 | $105.4K | 67,053 | SEC↗ |
| Setboun David | EVP and COO | P Buy | 2020-07-16 | 2020-07-16 | 5,000 | $12.95 | $64.8K | 55,000 | SEC↗ |
| ACC International Holdings Ltd | Other | S Sale | 2020-07-15 | 2020-07-16 | 18,430 | $13.12 | $241.8K | 74,876 | SEC↗ |
| Abbhi Sankesh | Director | P Buy | 2020-07-15 | 2020-07-16 | 46,779 | $12.99 | $607.7K | 2,164,530 | SEC↗ |
| ACC International Holdings Ltd | Other | S Sale | 2020-07-13 | 2020-07-16 | 40,000 | $13.52 | $540.8K | 93,306 | SEC↗ |
| ACC International Holdings Ltd | Other | S Sale | 2020-07-10 | 2020-07-16 | 2,000 | $13.35 | $26.7K | 133,306 | SEC↗ |
| ACC International Holdings Ltd | Other | S Sale | 2020-07-09 | 2020-07-16 | 3,500 | $13.13 | $46.0K | 135,306 | SEC↗ |
| Yablonka Uri | EVP & Chief Business Officer | A Award | 2020-06-23 | 2020-06-26 | 10,000 | — | $0 | 17,543 | SEC↗ |
| Lindborg Stacy | EVP, Head Global Clin Resear | A Award deriv | 2020-06-01 | 2020-06-01 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Lindborg Stacy | EVP, Head Global Clin Resear | A Award | 2020-06-01 | 2020-06-01 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Setboun David | EVP and COO | A Award | 2020-04-07 | 2020-04-07 | 50,000 | — | $0 | 50,000 | SEC↗ |
| FRENKEL JACOB A | Director | A Award deriv | 2020-04-06 | 2020-04-07 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Abbhi Sankesh | Director | A Award | 2020-04-06 | 2020-04-07 | 4,657 | — | $0 | 4,657 | SEC↗ |
| Kern Ralph Dr. | COO and Chief Medical Office | A Award deriv | 2020-03-09 | 2020-03-13 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Kern Ralph Dr. | COO and Chief Medical Office | A Award | 2020-03-06 | 2020-03-06 | 35,885 | — | $0 | 151,540 | SEC↗ |
| Polverino Anthony J. | Director | A Award | 2020-02-01 | 2020-02-14 | 3,071 | — | $0 | 15,862 | SEC↗ |
| Araya Arturo | Chief Commercial Officer | P Buy | 2019-12-24 | 2019-12-27 | 3,000 | $3.90 | $11.7K | 8,608 | SEC↗ |
| Shah Preetam | EVP, CFO and Treasurer | P Buy | 2019-12-24 | 2019-12-27 | 11,600 | $3.96 | $45.9K | 36,600 | SEC↗ |
| Kern Ralph Dr. | COO and Chief Medical Office | P Buy | 2019-12-24 | 2019-12-27 | 3,000 | $3.88 | $11.6K | 115,655 | SEC↗ |
| Yablonka Uri | EVP and Chief Business Offic | A Award deriv | 2019-12-12 | 2020-02-14 | 13,333 | — | $0 | 13,333 | SEC↗ |
| ARBEL IRIT | Director | A Award deriv | 2019-12-12 | 2020-02-14 | 25,333 | — | $0 | 25,333 | SEC↗ |
| Polverino Anthony J. | Director | A Award | 2019-12-12 | 2020-02-14 | 2,000 | — | $0 | 12,791 | SEC↗ |
| TAUB MALCOLM S | Director | A Award | 2019-12-12 | 2020-02-14 | 12,000 | — | $0 | 53,332 | SEC↗ |
| Almenoff June Sherie | Director | A Award | 2019-12-12 | 2020-02-14 | 2,000 | — | $0 | 2,000 | SEC↗ |
| Shah Preetam | EVP, CFO and Treasurer | A Award deriv | 2019-09-06 | 2019-09-09 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Shah Preetam | EVP, CFO and Treasurer | A Award deriv | 2019-09-06 | 2019-09-09 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Shah Preetam | EVP, CFO and Treasurer | A Award | 2019-09-06 | 2019-09-09 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ARBEL IRIT | Director | M Exercise deriv | 2019-08-28 | 2019-08-30 | 6,666 | — | $0 | 0 | SEC↗ |
| ARBEL IRIT | Director | M Exercise deriv | 2019-08-28 | 2019-08-30 | 6,666 | — | $0 | 0 | SEC↗ |
| ARBEL IRIT | Director | M Exercise | 2019-08-28 | 2019-08-30 | 6,666 | $2.25 | $15.0K | 169,165 | SEC↗ |
| ARBEL IRIT | Director | M Exercise | 2019-08-28 | 2019-08-30 | 6,666 | $2.25 | $15.0K | 162,499 | SEC↗ |
| ARBEL IRIT | Director | S Sale | 2019-08-28 | 2019-08-30 | 13,332 | $3.67 | $48.9K | 155,833 | SEC↗ |
| Lebovits Chaim | See Remarks | A Award | 2019-07-26 | 2019-07-26 | 31,185 | — | $0 | 2,166,155 | SEC↗ |
| Kern Ralph Dr. | COO and Chief Medical Office | A Award | 2019-03-06 | 2019-03-08 | 35,885 | — | $0 | 112,655 | SEC↗ |
| Polverino Anthony J. | Director | A Award | 2019-02-01 | 2019-02-22 | 3,501 | — | $0 | 10,791 | SEC↗ |
| Almenoff June Sherie | Director | P Buy | 2019-01-04 | 2019-01-08 | 1,475 | $3.39 | $5.0K | 7,175 | SEC↗ |
| Yablonka Uri | EVP and Chief Business Offic | A Award deriv | 2018-11-30 | 2018-11-30 | 13,333 | — | $0 | 13,333 | SEC↗ |
| ARBEL IRIT | Director | A Award deriv | 2018-11-30 | 2018-11-30 | 25,333 | — | $0 | 25,333 | SEC↗ |
| TAUB MALCOLM S | Director | A Award | 2018-11-30 | 2018-11-30 | 12,000 | — | $0 | 41,332 | SEC↗ |
| Polverino Anthony J. | Director | A Award | 2018-11-30 | 2018-11-30 | 1,667 | — | $0 | 7,290 | SEC↗ |
| Polverino Anthony J. | Director | A Award | 2018-11-30 | 2018-11-30 | 2,000 | — | $0 | 5,623 | SEC↗ |
| Schor Chen | Director | A Award | 2018-11-30 | 2018-11-30 | 2,000 | — | $0 | 125,558 | SEC↗ |
| Schor Chen | Director | G Gift | 2018-10-24 | 2018-12-21 | 121,558 | — | $0 | 4,000 | SEC↗ |
| Schor Chen | Director | G Gift | 2018-10-24 | 2018-12-21 | 121,558 | — | $0 | 121,558 | SEC↗ |
| Araya Arturo | Chief Commercial Officer | A Award deriv | 2018-08-28 | 2018-09-04 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Araya Arturo | Chief Commercial Officer | D To issuer | 2018-08-28 | 2018-09-04 | 2,805 | — | $0 | 5,608 | SEC↗ |
| Lebovits Chaim | See Remarks | A Award | 2018-07-26 | 2018-07-27 | 31,185 | — | $0 | 2,134,970 | SEC↗ |
| Araya Arturo | Director | A Award | 2018-03-26 | 2018-03-26 | 1,249 | — | $0 | 8,413 | SEC↗ |
| Almenoff June Sherie | Director | A Award | 2018-03-15 | 2018-03-16 | 5,700 | $3.50 | $19.9K | 5,700 | SEC↗ |
| Kern Ralph Dr. | COO and Chief Medical Office | A Award | 2018-03-15 | 2018-03-19 | 5,000 | $3.60 | $18.0K | 40,885 | SEC↗ |
| Kern Ralph Dr. | COO and Chief Medical Office | P Buy | 2018-03-15 | 2018-03-20 | 5,000 | $3.60 | $18.0K | 40,885 | SEC↗ |
| Almenoff June Sherie | Director | P Buy | 2018-03-15 | 2018-03-20 | 5,700 | $3.50 | $19.9K | 5,700 | SEC↗ |
| Kern Ralph Dr. | COO and Chief Medical Office | A Award | 2018-03-06 | 2018-03-26 | 35,885 | — | $0 | 76,770 | SEC↗ |
| Araya Arturo | Director | A Award | 2018-02-26 | 2018-02-28 | 4,152 | — | $0 | 7,164 | SEC↗ |
| Polverino Anthony J. | Director | A Award | 2018-02-01 | 2018-02-05 | 3,623 | — | $0 | 3,623 | SEC↗ |
| Rubin Eyal | CFO and Treasurer | A Award deriv | 2017-11-20 | 2017-11-20 | 93,686 | — | $0 | 93,686 | SEC↗ |
| Rubin Eyal | CFO and Treasurer | A Award | 2017-11-20 | 2017-11-20 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Yablonka Uri | EVP and Chief Business Offic | A Award deriv | 2017-11-10 | 2017-11-13 | 13,333 | — | $0 | 13,333 | SEC↗ |
| ARBEL IRIT | Director | A Award deriv | 2017-11-10 | 2017-11-13 | 25,333 | — | $0 | 25,333 | SEC↗ |
| Schor Chen | Director | A Award | 2017-11-10 | 2017-11-13 | 2,000 | — | $0 | 123,558 | SEC↗ |
| TAUB MALCOLM S | Director | A Award | 2017-11-10 | 2017-11-13 | 12,000 | — | $0 | 29,332 | SEC↗ |
| SHORR ROBERT G L | Director | A Award | 2017-11-10 | 2017-11-13 | 8,666 | — | $0 | 45,731 | SEC↗ |
| ARBEL IRIT | Director | P Buy | 2017-08-31 | 2017-08-31 | 2,500 | $4.26 | $10.7K | 155,833 | SEC↗ |
| Yablonka Uri | EVP & Chief Business Officer | P Buy | 2017-08-23 | 2017-08-23 | 2,000 | $3.98 | $8.0K | 7,543 | SEC↗ |
| Lebovits Chaim | See Remarks | A Award deriv | 2017-07-26 | 2017-07-26 | 41,580 | — | $0 | 41,580 | SEC↗ |
| Lebovits Chaim | See Remarks | A Award | 2017-07-26 | 2017-07-26 | 31,185 | — | $0 | 2,103,785 | SEC↗ |
| ARBEL IRIT | Director | A Award deriv | 2017-07-13 | 2017-07-17 | 12,000 | — | $0 | 12,000 | SEC↗ |
| Yablonka Uri | EVP & Chief Business Officer | A Award | 2017-07-13 | 2017-07-17 | 5,543 | — | $0 | 5,543 | SEC↗ |
| Kern Ralph Dr. | COO and Chief Medical Office | A Award deriv | 2017-03-06 | 2017-03-06 | 47,847 | — | $0 | 47,847 | SEC↗ |
| Kern Ralph Dr. | COO and Chief Medical Office | A Award | 2017-03-06 | 2017-03-06 | 35,885 | — | $0 | 35,885 | SEC↗ |
| ARBEL IRIT | Director | A Award deriv | 2017-02-26 | 2017-02-28 | 6,667 | — | $0 | 6,667 | SEC↗ |
| Araya Arturo | Director | A Award | 2017-02-26 | 2017-03-03 | 3,012 | — | $0 | 3,012 | SEC↗ |
| Yablonka Uri | Chief Operating Officer | A Award deriv | 2016-06-22 | 2016-06-23 | 13,333 | — | $0 | 13,333 | SEC↗ |
| Pinkas Alon | Director | A Award deriv | 2016-06-22 | 2016-06-23 | 15,333 | — | $0 | 15,333 | SEC↗ |
| Friedman Mordechai | Director | A Award deriv | 2016-06-22 | 2016-06-23 | 16,666 | — | $0 | 16,666 | SEC↗ |
| ARBEL IRIT | Director | A Award deriv | 2016-06-22 | 2016-06-23 | 25,333 | — | $0 | 25,333 | SEC↗ |
| SHORR ROBERT G L | Director | A Award | 2016-06-22 | 2016-06-23 | 8,666 | — | $0 | 37,065 | SEC↗ |
| TAUB MALCOLM S | Director | A Award | 2016-06-22 | 2016-06-23 | 8,666 | — | $0 | 17,332 | SEC↗ |
| SHORR ROBERT G L | Director | S Sale | 2015-12-16 | 2015-12-17 | 10,800 | $2.71 | $29.3K | 28,399 | SEC↗ |
| TAUB MALCOLM S | Director | S Sale | 2015-12-15 | 2015-12-16 | 11,263 | $2.59 | $29.2K | 8,666 | SEC↗ |
| Friedman Mordechai | Director | M Exercise deriv | 2015-12-14 | 2015-12-16 | 5,000 | — | $0 | 11,666 | SEC↗ |
| TAUB MALCOLM S | Director | S Sale | 2015-12-14 | 2015-12-16 | 30,479 | $2.61 | $79.6K | 19,929 | SEC↗ |
| Friedman Mordechai | Director | M Exercise | 2015-12-14 | 2015-12-16 | 5,000 | $0.75 | $3.8K | 5,000 | SEC↗ |
| Friedman Mordechai | Director | S Sale | 2015-12-14 | 2015-12-16 | 5,000 | $2.57 | $12.8K | 0 | SEC↗ |
| TAUB MALCOLM S | Director | S Sale | 2015-12-11 | 2015-12-14 | 980 | $2.66 | $2.6K | 50,408 | SEC↗ |
| SHORR ROBERT G L | Director | S Sale | 2015-12-11 | 2015-12-14 | 5,300 | $2.56 | $13.6K | 39,199 | SEC↗ |
| TAUB MALCOLM S | Director | S Sale | 2015-12-10 | 2015-12-14 | 12,500 | $2.74 | $34.3K | 51,388 | SEC↗ |
| SHORR ROBERT G L | Director | S Sale | 2015-12-10 | 2015-12-14 | 5,500 | $2.71 | $14.9K | 44,499 | SEC↗ |
| Bibring Yoram | Chief Financial Officer | D To issuer deriv | 2015-12-01 | 2015-12-03 | 82,500 | — | $0 | 82,500 | SEC↗ |
| ACC International Holdings Ltd | Other | P Buy | 2015-10-01 | 2015-10-02 | 2,000 | $2.58 | $5.2K | 138,806 | SEC↗ |
| ACC International Holdings Ltd | Other | P Buy | 2015-09-30 | 2015-10-01 | 9,200 | $2.34 | $21.5K | 136,806 | SEC↗ |
| Lebovits Chaim | See Remarks | A Award deriv | 2015-09-28 | 2015-10-01 | 369,619 | — | $0 | 369,619 | SEC↗ |
| Lebovits Chaim | See Remarks | A Award deriv | 2015-09-28 | 2015-10-13 | 369,619 | — | $0 | 369,619 | SEC↗ |
| ARBEL IRIT | Director | A Award deriv | 2015-08-27 | 2015-08-31 | 25,333 | — | $0 | 25,333 | SEC↗ |
| Friedman Mordechai | Director | A Award deriv | 2015-08-27 | 2015-08-31 | 16,666 | — | $0 | 16,666 | SEC↗ |
| Pinkas Alon | Director | A Award deriv | 2015-08-27 | 2015-08-31 | 15,333 | — | $0 | 15,333 | SEC↗ |
| Yablonka Uri | Chief Operating Officer | A Award deriv | 2015-08-27 | 2015-08-31 | 13,333 | — | $0 | 13,333 | SEC↗ |
| TAUB MALCOLM S | Director | A Award | 2015-08-27 | 2015-08-31 | 8,666 | — | $0 | 50,554 | SEC↗ |
| SHORR ROBERT G L | Director | A Award | 2015-08-27 | 2015-08-31 | 8,666 | — | $0 | 49,999 | SEC↗ |
| Bibring Yoram | Chief Financial Officer | P Buy | 2015-08-20 | 2015-08-21 | 8,500 | $3.04 | $25.8K | 50,000 | SEC↗ |
| Bibring Yoram | Chief Financial Officer | P Buy | 2015-08-17 | 2015-08-19 | 41,500 | $2.92 | $121.2K | 41,500 | SEC↗ |
| Bibring Yoram | Chief Financial Officer | A Award deriv | 2015-07-30 | 2015-08-03 | 165,000 | — | $0 | 165,000 | SEC↗ |
| ARBEL IRIT | Director | A Award deriv | 2015-06-01 | 2015-06-03 | 6,667 | — | $0 | 6,667 | SEC↗ |
| Schor Chen | Director | A Award | 2015-05-03 | 2015-05-05 | 60,000 | — | $0 | 121,558 | SEC↗ |
| Fiorino Anthony S. | Chief Executive Officer | P Buy | 2014-10-15 | 2014-10-15 | 200 | $3.59 | $718 | 2,200 | SEC↗ |
| Fiorino Anthony S. | Chief Executive Officer | P Buy | 2014-10-15 | 2014-10-15 | 300 | $3.60 | $1.1K | 2,500 | SEC↗ |
| ACC International Holdings Ltd | Other | P Buy | 2014-10-10 | 2014-10-15 | 300 | $3.95 | $1.2K | 126,606 | SEC↗ |
| ACC International Holdings Ltd | Other | P Buy | 2014-10-10 | 2014-10-15 | 400 | $4.01 | $1.6K | 126,306 | SEC↗ |
| ACC International Holdings Ltd | Other | P Buy | 2014-10-10 | 2014-10-15 | 700 | $3.95 | $2.8K | 127,306 | SEC↗ |
| ACC International Holdings Ltd | Other | P Buy | 2014-10-10 | 2014-10-15 | 300 | $4.00 | $1.2K | 127,606 | SEC↗ |
| ACC International Holdings Ltd | Other | P Buy | 2014-10-10 | 2014-10-15 | 400 | $3.98 | $1.6K | 125,906 | SEC↗ |
| ACC International Holdings Ltd | Other | P Buy | 2014-10-10 | 2014-10-15 | 1,300 | $3.98 | $5.2K | 125,506 | SEC↗ |
| ACC International Holdings Ltd | Other | P Buy | 2014-10-10 | 2014-10-15 | 600 | $4.01 | $2.4K | 124,206 | SEC↗ |
| ACC International Holdings Ltd | Other | P Buy | 2014-10-10 | 2014-10-15 | 600 | $4.04 | $2.4K | 123,606 | SEC↗ |
| ACC International Holdings Ltd | Other | P Buy | 2014-10-10 | 2014-10-15 | 300 | $4.05 | $1.2K | 123,006 | SEC↗ |
| ACC International Holdings Ltd | Other | P Buy | 2014-10-10 | 2014-10-15 | 200 | $4.08 | $816 | 122,706 | SEC↗ |
| ACC International Holdings Ltd | Other | P Buy | 2014-10-10 | 2014-10-15 | 2,500 | $4.09 | $10.2K | 122,506 | SEC↗ |
| ACC International Holdings Ltd | Other | P Buy | 2014-10-10 | 2014-10-15 | 1,000 | $4.29 | $4.3K | 120,006 | SEC↗ |
| ACC International Holdings Ltd | Other | P Buy | 2014-10-01 | 2014-10-01 | 3,600 | $4.08 | $14.7K | 119,006 | SEC↗ |
| ACC International Holdings Ltd | Other | P Buy | 2014-09-30 | 2014-10-01 | 1,000 | $4.32 | $4.3K | 115,406 | SEC↗ |
| ACC International Holdings Ltd | Other | P Buy | 2014-09-30 | 2014-10-01 | 500 | $4.22 | $2.1K | 114,406 | SEC↗ |
| ACC International Holdings Ltd | Other | P Buy | 2014-09-29 | 2014-10-01 | 1,000 | $4.12 | $4.1K | 113,906 | SEC↗ |
| ACC International Holdings Ltd | Other | P Buy | 2014-09-29 | 2014-10-01 | 500 | $4.17 | $2.1K | 112,906 | SEC↗ |
| ACC International Holdings Ltd | Other | P Buy | 2014-09-29 | 2014-10-01 | 100 | $4.18 | $418 | 112,406 | SEC↗ |
| ACC International Holdings Ltd | Other | P Buy | 2014-09-22 | 2014-09-24 | 500 | $4.05 | $2.0K | 104,306 | SEC↗ |
| ACC International Holdings Ltd | Other | P Buy | 2014-09-22 | 2014-09-24 | 300 | $4.10 | $1.2K | 104,606 | SEC↗ |
| ACC International Holdings Ltd | Other | P Buy | 2014-09-22 | 2014-09-24 | 500 | $4.14 | $2.1K | 105,106 | SEC↗ |
| ACC International Holdings Ltd | Other | P Buy | 2014-09-22 | 2014-09-24 | 300 | $4.18 | $1.3K | 105,406 | SEC↗ |
| ACC International Holdings Ltd | Other | P Buy | 2014-09-22 | 2014-09-24 | 500 | $4.20 | $2.1K | 105,906 | SEC↗ |
| ACC International Holdings Ltd | Other | P Buy | 2014-09-22 | 2014-09-24 | 1,200 | $4.23 | $5.1K | 107,106 | SEC↗ |
| ACC International Holdings Ltd | Other | P Buy | 2014-09-22 | 2014-09-24 | 1,000 | $4.27 | $4.3K | 108,106 | SEC↗ |
| ACC International Holdings Ltd | Other | P Buy | 2014-09-22 | 2014-09-24 | 1,800 | $4.30 | $7.7K | 112,306 | SEC↗ |
| ACC International Holdings Ltd | Other | P Buy | 2014-09-22 | 2014-09-24 | 2,000 | $4.29 | $8.6K | 110,506 | SEC↗ |
| ACC International Holdings Ltd | Other | P Buy | 2014-09-22 | 2014-09-24 | 400 | $4.28 | $1.7K | 108,506 | SEC↗ |
| ACC International Holdings Ltd | Other | P Buy | 2014-09-19 | 2014-09-24 | 1,500 | $3.90 | $5.8K | 102,806 | SEC↗ |
| ACC International Holdings Ltd | Other | P Buy | 2014-09-19 | 2014-09-24 | 1,000 | $3.94 | $3.9K | 103,806 | SEC↗ |
| Fiorino Anthony S. | Chief Executive Officer | P Buy | 2014-09-18 | 2014-09-19 | 800 | $3.84 | $3.1K | 2,000 | SEC↗ |
| Fiorino Anthony S. | Chief Executive Officer | P Buy | 2014-09-15 | 2014-09-16 | 5,000 | $0.29 | $1.4K | 15,000 | SEC↗ |
| Fiorino Anthony S. | Chief Executive Officer | P Buy | 2014-09-15 | 2014-09-16 | 3,000 | $0.28 | $840 | 18,000 | SEC↗ |
| Fiorino Anthony S. | Chief Executive Officer | P Buy | 2014-09-12 | 2014-09-16 | 2,500 | $0.28 | $700 | 2,500 | SEC↗ |
| Fiorino Anthony S. | Chief Executive Officer | P Buy | 2014-09-12 | 2014-09-16 | 7,500 | $0.29 | $2.2K | 10,000 | SEC↗ |
| Pinkas Alon | Director | A Award deriv | 2014-08-15 | 2014-08-19 | 230,000 | — | $0 | 230,000 | SEC↗ |
| Yablonka Uri | Chief Operating Officer | A Award deriv | 2014-08-15 | 2014-08-19 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Friedman Mordechai | Director | A Award deriv | 2014-08-15 | 2014-08-19 | 250,000 | — | $0 | 250,000 | SEC↗ |
| ARBEL IRIT | Director | A Award deriv | 2014-08-15 | 2014-08-19 | 380,000 | — | $0 | 380,000 | SEC↗ |
| SHORR ROBERT G L | Director | A Award | 2014-08-15 | 2014-08-19 | 130,000 | — | $0 | 620,000 | SEC↗ |
| TAUB MALCOLM S | Director | A Award | 2014-08-15 | 2014-08-19 | 130,000 | — | $0 | 628,333 | SEC↗ |
| ACC International Holdings Ltd | Other | P Buy | 2014-06-16 | 2014-06-20 | 130,000 | $0.29 | $37.7K | 1,519,600 | SEC↗ |
| ACC International Holdings Ltd | Other | P Buy | 2014-06-13 | 2014-06-16 | 150,000 | $0.35 | $52.5K | 1,389,600 | SEC↗ |
| Fiorino Anthony S. | Chief Executive Officer | A Award deriv | 2014-06-09 | 2014-06-10 | 5,700,000 | — | $0 | 5,700,000 | SEC↗ |
| Yablonka Uri | Chief Operating Officer | A Award deriv | 2014-06-06 | 2014-06-09 | 500,000 | — | $0 | 500,000 | SEC↗ |
| ACC International Holdings Ltd | Other | P Buy | 2014-04-28 | 2014-05-02 | 939,600 | $0.30 | $281.9K | 1,239,600 | SEC↗ |
| Israeli Avi | Director | A Award deriv | 2014-04-13 | 2014-04-14 | 133,334 | — | $0 | 133,334 | SEC↗ |
| Israeli Avi | Director | A Award deriv | 2014-04-13 | 2014-04-14 | 166,666 | — | $0 | 166,666 | SEC↗ |
| Sossover Liat | Chief Financial Officer | A Award deriv | 2013-12-31 | 2014-01-03 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ARBEL IRIT | Director | A Award deriv | 2013-04-19 | 2013-04-23 | 180,000 | — | $0 | 180,000 | SEC↗ |
| Pinkas Alon | Director | A Award deriv | 2013-04-19 | 2013-04-23 | 130,000 | — | $0 | 130,000 | SEC↗ |
| Friedman Mordechai | Director | A Award deriv | 2013-04-19 | 2013-04-23 | 150,000 | — | $0 | 150,000 | SEC↗ |
| SHORR ROBERT G L | Director | A Award | 2013-04-19 | 2013-04-23 | 130,000 | — | $0 | 490,000 | SEC↗ |
| TAUB MALCOLM S | Director | A Award | 2013-04-19 | 2013-04-23 | 130,000 | — | $0 | 498,333 | SEC↗ |
| Israeli Avi | Director | A Award deriv | 2013-04-13 | 2013-04-23 | 166,666 | — | $0 | 166,666 | SEC↗ |
| Sossover Liat | Chief Financial Officer | A Award deriv | 2012-08-01 | 2012-08-03 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Harel Adrian | Chief Executive Officer | A Award deriv | 2012-08-01 | 2012-08-03 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Harel Adrian | Chief Executive Officer | A Award deriv | 2012-08-01 | 2012-08-27 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Sossover Liat | Chief Financial Officer | A Award deriv | 2012-08-01 | 2012-08-27 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Friedman Mordechai | Director | A Award deriv | 2012-08-01 | 2012-09-06 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Pinkas Alon | Director | A Award deriv | 2012-08-01 | 2012-09-06 | 130,000 | — | $0 | 130,000 | SEC↗ |
| ARBEL IRIT | Director | A Award deriv | 2012-08-01 | 2012-09-06 | 180,000 | — | $0 | 180,000 | SEC↗ |
| TAUB MALCOLM S | Director | A Award | 2012-08-01 | 2012-08-03 | 130,000 | — | $0 | 368,333 | SEC↗ |
| SHORR ROBERT G L | Director | A Award | 2012-08-01 | 2012-08-03 | 130,000 | — | $0 | 360,000 | SEC↗ |
| Israeli Avi | Director | A Award deriv | 2012-04-13 | 2012-04-17 | 166,666 | — | $0 | 166,666 | SEC↗ |